|
05 Jan 2007 |
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
|
|
05 Jan 2007 |
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
|
|
05 Jan 2007 |
Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
|
|
05 Jan 2007 |
Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
|
|
05 Jan 2007 |
Ecopia Announces Agreement with Caprion to Combine Their Businesses and Launch a $30 Million Private Placement
|
|
05 Jan 2007 |
BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
|
|
05 Jan 2007 |
AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
|
|
05 Jan 2007 |
Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
|
|
04 Jan 2007 |
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
|
|
04 Jan 2007 |
Sembiosys To Proceed With Abbreviated Regulatory Path For Plant- Produced Insulin After Meeting With The FDA
|
|
04 Jan 2007 |
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
|
|
04 Jan 2007 |
Gentium Acquires Italian Defibrotide Marketing Rights from Crinos
|
|
04 Jan 2007 |
DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
|
|
04 Jan 2007 |
Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
|
|
03 Jan 2007 |
Galapagos expands and extends drug discovery collaboration with Amgen into 2008
|
|
03 Jan 2007 |
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
|
|
03 Jan 2007 |
Ranbaxy Granted Final Usfda Approval To Manufacture And Market Atenolol Tablets
|
|
03 Jan 2007 |
Lupin Pharmaceuticals, Inc. Announces Tentative Approval Of Generic ZOLOFT(R)
|
